MarketFriction

Krsnaa Diagnostics Ltd

NSE KRSNAA · BSE 543328 · Healthcare Service Provider
₹554.85 -0.91%
NSE close2026-10-01
52 week range515.00 - 848.10
Market cap₹1,791 Cr.
P/E18.1
IPO 2021 · -42% since Price band 20% Delivery 60.0%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales147152159163179165175176183159173211
Expenses116113116120126117121126125112116154
Operating Profit313843435248535058485757
OPM %21%25%27%26%29%29%31%29%32%30%33%27%
Other Income4447594444317
Interest34756676881215
Depreciation182118212223222223232228
Profit before tax141722242828292631215422
Tax %20%20%17%23%23%24%28%26%24%22%20%26%
Net Profit111418182222212023164316
EPS in Rs3.604.215.705.636.806.696.536.037.165.0813.374.88
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales3657108147258396455464590682691726
Expenses354216987373302320340444485478507
Operating Profit015-6260-11494135124146197213219
OPM %0.6%26%-57%41%-44%24%30%27%25%29%31%30%
Other Income343213265151917264347
Interest66816252618816253442
Depreciation51018263237415475889096
Profit before tax-72-8421-158295908272110132128
Tax %6%8%-29%40%-29%37%21%23%19%24%22%
Net Profit-82-6012-1121857164598310399
EPS in Rs-15.054.01-116.5424.15-216.83284.7322.5220.2318.1425.6531.6530.49
Dividend Payout %0%0%0%0%0%0%11%14%14%11%6%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth35%12%14%5%
Compounded Profit Growth31%-11%17%17%
Stock Price CAGR%-6%-7%-28%
Return on Equity%10%9%11%
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital555561616161616
Reserves4643-217-17671727799877976
Borrowings1311023302464744132160202531
Other Liabilities2463115596146149134197188295
Total Liabilities1631764936306098779091,1721,2831,818
Fixed Assets59116223275309386471647668651
CWIP20642942825103208
Investments000000003258
Other Assets8553228345297463413514581902
Total Assets1631764936306098779091,1721,2831,818
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity596138119129752489134
Cash from Investing Activity-53-201-77-67-241-109-129-102-391
Cash from Financing Activity-37145620176-338414278
Net Cash Flow-314-337164-66-20122
Free Cash Flow6-42-3950-2-59-169-21-80
CFO/OP410%114%-42%134%100%71%30%55%75%
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days879114087694859110152163
Inventory Days212489
Days Payable7699878
Cash Conversion Cycle3215-65087694859110152163
Working Capital Days-428-119-234-133-82-2116-182866
ROCE %7%-65%129%18%12%10%13%13%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters27.79%27.03%27.03%27.17%27.17%27.24%27.24%27.11%27.11%27.11%27.11%27.11%
FIIs3.68%3.44%3.34%3.33%3.63%4.04%3.55%3.40%3.66%4.17%3.91%4.28%
DIIs18.73%16.59%15.37%15.26%15.86%14.46%14.26%14.24%14.96%13.85%13.89%14.51%
Public49.79%52.94%54.27%54.23%53.34%54.27%54.94%55.25%54.27%54.86%55.09%54.08%
No. of Shareholders60,66557,23256,45855,91453,51952,79953,55954,26252,11752,38053,02253,625

Fundamentals

Market Cap₹ 1,791 Cr.
Current Price₹ 554
Stock P/E18.1
Book Value₹ 306
ROCE12.7 %
ROE10.9 %
Dividend Yield0.36 %
Face Value₹ 5.00
Compounded Sales Growth (TTM)5%
Compounded Profit Growth (TTM)17%
Standalone figures.
Valuation
Market capRs 1,800 Cr
Enterprise valueRs 1,975 Cr
P/E (TTM)18.19x
Price to book1.81x
Price to sales2.48x
EV / EBITDA7.43x
EV / EBIT11.63x
EV / sales2.72x
Price to cash flow13.42x
Earnings yield5.50%
Dividend yield0.36%
P/E, 3-year average27.02x
P/B, 3-year average2.33x
P/E, 5-year average25.10x
P/B, 5-year average2.23x
Profitability
Operating margin (excl. other income)30.78%
Operating margin (incl. other income)37.05%
EBITDA margin36.62%
Pre-tax margin17.56%
Net profit margin13.63%
Net margin, latest quarter7.51%
ROE10.89%
ROCE12.70%
ROA6.62%
ROE, 3-year average9.37%
ROCE, 3-year average11.92%
ROA, 3-year average6.33%
ROE, 5-year average11.58%
ROCE, 5-year average13.18%
ROA, 5-year average7.12%
ROIC (approx.)11.29%
Tax rate22.41%
Other income / net worth4.37%
Growth
Sales growth (latest year)1.36%
Profit growth (latest year)23.99%
Sales CAGR, 3 years14.19%
Sales CAGR, 5 years11.75%
Profit CAGR, 3 years17.37%
Profit CAGR, 5 years-11.10%
Sales growth QoQ21.75%
Profit growth QoQ-63.53%
Sales growth YoY (latest quarter)19.95%
Profit growth YoY (latest quarter)-19.12%
Per share
EPS (TTM)Rs 30.50
EPS (latest year)Rs 31.65
EPS (latest quarter)Rs 4.88
EPS, 3-year averageRs 25.15
EPS, 5-year averageRs 23.64
Book value per shareRs 305.78
Sales per shareRs 223.80
Cash flow per shareRs 41.34
Free cash flow per shareRs -24.66
Dividend per share (latest year)Rs 2.00
Dividend per share, 3-year averageRs 2.42
Dividend per share, 5-year averageRs 2.50
Dividends
Dividend payout6.32%
Dividend payout, 3-year average10.28%
Dividend payout, 5-year average11.11%
Efficiency
Asset turnover0.38x
Fixed asset turnover1.06x
Inventory turnover8.02x
Inventory days45 days
Debtor days163 days
Debtors turnover2.24x
Creditor days878 days
Cash conversion cycle163 days
Working capital days66 days
Leverage
Total debtRs 531 Cr
Cash and bankRs 356 Cr
Net debtRs 176 Cr
Debt to equity0.54x
Net debt / EBITDA0.66x
Interest coverage4.01x
Current ratio (filing 2026-03-31)2.82x
Quick ratio (filing 2026-03-31)2.72x
Trade payables (filing 2026-03-31)Rs 57 Cr
Owners' fund to total sources54.55%
Debt to assets29.21%
Cash flow
Cash from Operating Activity (latest year)Rs 134 Cr
Cash from Investing Activity (latest year)Rs -391 Cr
Cash from Financing Activity (latest year)Rs 278 Cr
Net Cash Flow (latest year)Rs 22 Cr
Free cash flow (latest year)Rs -80 Cr
FCFE (approx.: FCF + change in debt)Rs 250 Cr
Cash from ops / profit, 5 years1.19x
Sales to cash flow5.15x
Statement figures
Net sales (TTM)Rs 726 Cr
Net sales (latest year)Rs 691 Cr
Sales (latest quarter)Rs 211 Cr
Operating profit excl. other income (latest year)Rs 213 Cr
Operating profit (latest quarter)Rs 57 Cr
Other income (TTM)Rs 47 Cr
EBITDA (TTM)Rs 266 Cr
PBDT (TTM)Rs 223 Cr
Profit before tax (TTM)Rs 128 Cr
Tax (latest year)Rs 30 Cr
Net profit (TTM)Rs 99 Cr
Net profit (latest year)Rs 103 Cr
Net profit (latest quarter)Rs 16 Cr
Depreciation (TTM)Rs 96 Cr
Depreciation (latest quarter)Rs 28 Cr
Interest (TTM)Rs 42 Cr
Cost of goods sold (latest year)Rs 206 Cr
Total expenditure (latest year)Rs 478 Cr
Total income (latest year)Rs 734 Cr
Share capitalRs 16 Cr
ReservesRs 976 Cr
Shareholders' fundsRs 992 Cr
Total assetsRs 1,818 Cr
Net blockRs 651 Cr
Capital work in progressRs 208 Cr
InvestmentsRs 58 Cr
ReceivablesRs 308 Cr
InventoryRs 26 Cr
Other liabilitiesRs 295 Cr
Shares outstanding (crore)3.24
Ownership
Promoter holding27.11% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 18.2 is at the 24th percentile of its own 5.2-year range (median 26.4, low 8.6, high 55.1).
P/B 1.81 is at the 6th percentile (median 2.59).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodKRSNAANifty 50Difference
1 week+0.7%-2.8% +3.4 pts
1 month-0.9%-6.8% +5.9 pts
3 months-1.4%-7.6% +6.2 pts
6 months+6.6%+0.4% +6.2 pts
1 year-31.7%-9.9% -21.8 pts
2 years-35.7%-13.6% -22.1 pts
3 years-18.6%+14.2% -32.7 pts
5 years-27.1%+27.9% -55.0 pts
9 mutual fund schemes hold about ₹183 Cr. Over three months 1 bought more and 1 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Tata Small Cap Fund1.10%144 -1%
Bandhan Small Cap Fund0.10%35 -14%
Shriram Multi Sector Rotation Fund1.50%2 +9%
Shriram Multi Asset Allocation Fund0.10%0 -2%
Shriram ELSS Tax Saver Fund0.16%0 +2%
Shriram Balanced Advantage Fund0.12%0 +3%
Shriram Aggressive Hybrid Fund0.10%0 -1%
Bandhan BSE Healthcare Index Fund0.06%0 -0%
Motilal Oswal BSE 1000 Index Fund0.01%0

Red flags

F-score 5 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹211 Cr +19.9% vs Jun 2025. Net profit ₹16 Cr -20.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Dr Lal Pathlabs Ltd32,73758.228.0 %
Vijaya Diagnostic Centre Ltd15,19281.020.5 %
Metropolis Healthcare Ltd11,66556.017.8 %
Thyrocare Technologies Ltd8,70848.235.4 %
Nephrocare Health Services Ltd6,67178.415.3 %
Suraksha Diagnostic Ltd1,84751.617.3 %
3B Blackbio DX Ltd1,39625.125.5 %
One Global Service Provider Ltd1,04614.187.0 %
Health X Platform Ltd9230.03 %
Gaudium IVF and Women Health Ltd83035.929.3 %
Chandan Healthcare Ltd58122.123.3 %
Pramodini Medicare Ltd25914.941.8 %
Aspira Pathlab & Diagnostics Ltd1482.84 %
Choksi Laboratories Ltd13269.29.44 %
Star Imaging and Path Lab Ltd1316.8026.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-09-18Dividend - Rs 2 Per Share
2025-09-12Dividend - Rs 2.75 Per Share
2024-09-13Dividend - Rs 2.50 Per Share
2024-09-13Annual General Meeting
2023-09-15Dividend - Rs 2.75 Per Share
2023-09-15Annual General Meeting
2022-09-15Dividend - Rs 2.50 Per Share
DateTypeWhat it says
2026-09-30Shareholder meetingSubmission of Revised Voting Results.
2026-09-30General UpdatesGeneral Updates
2026-09-30Shareholder meetingVoting results.
2026-09-28General UpdatesGeneral Updates
2026-09-28Shareholder meetingProceedings of Annual General Meeting held on September 28, 2026
2026-09-18Shareholder meetingVoting results.
2026-09-16General UpdatesGeneral Updates
2026-09-11General UpdatesGeneral Updates
2026-09-09General UpdatesGeneral Updates
2026-09-05Shareholder meetingNotice of Annual General Meeting to be held on September 28, 2026
2026-08-28CorrigendumCorrigendum to Notice of Postal Ballot
2026-08-26General UpdatesGeneral Updates
2026-08-20General UpdatesGeneral Updates
2026-08-19Concall / analyst meetTranscript
2026-08-18Shareholder meetingShareholders meeting
2026-08-14Concall / analyst meetLink of Recording
2026-08-14Investor PresentationInvestor Presentation
2026-08-13Press ReleaseA press release dated August 13, 2026, titled "Promoters Back the Platform: Krsnaa Approves Preferential Warrant Issue as Revenue Grows 22% and Rajast...
2026-08-13General UpdatesGeneral Updates
2026-08-13Record DateRecord date for the purpose of Dividend is 18-Sep-2026.
2026-08-13General UpdatesGeneral Updates
2026-08-13Board meeting outcomeOutcome of Board Meeting held on August 13, 2026.
2026-08-13Board meeting outcomeKrsnaa Diagnostics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-07Concall / analyst meetSchedule of meet
2026-07-23General UpdatesGeneral Updates
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.Updated 2026-10-03